Who Exports Trimethoprim from India — 278 Suppliers Behind a $26.4M Market
India's trimethoprim export market is supplied by 278 active exporters who collectively shipped $26.4M across 2,427 shipments. MICRO LABS LIMITED leads with a 28.4% market share, followed by LEBEN LABORATORIES PRIVATE LIMITED and MEDICAMEN BIOTECH LIMITED. The top 5 suppliers together control 45.4% of total export value, reflecting a moderately competitive market structure.
Top Trimethoprim Exporters from India — Ranked by Export Value
MICRO LABS LIMITED is the leading trimethoprim exporter from India, holding a 28.4% share of the $26.4M market across 2,427 shipments from 278 exporters. The top 5 suppliers — MICRO LABS LIMITED, LEBEN LABORATORIES PRIVATE LIMITED, MEDICAMEN BIOTECH LIMITED, AUROBINDO PHARMA LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — collectively control 45.4% of total export value, indicating a competitive market. Individual shares are: MICRO LABS LIMITED (28.4%), LEBEN LABORATORIES PRIVATE LIMITED (4.5%), MEDICAMEN BIOTECH LIMITED (4.4%), AUROBINDO PHARMA LIMITED (4.2%), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED (4.0%).
Top Trimethoprim Exporters from India
Ranked by export value · 278 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED TRIMETHOPRIM AND SULFAMETHOXAZOLE TABLETORIPRIM TABLETS (TRIMETHOPRIM 80MG+SULPHTRIMETHOPRIME AND SUPFAMETHOXAZOLE TABLE | $7.5M | 19 | 28.4% |
| 2 | LEBEN LABORATORIES PRIVATE LIMITED TRIMETHOPRIM AND SULFAMETHOXAZOLE TABLETSULPHAMETHOXAZOLE+TRIMETHOPRIM (800 MG+1TRIMETHOPRIME AND SUPFAMETHOXAZOLE TABLE | $1.2M | 5 | 4.5% |
| 3 | MEDICAMEN BIOTECH LIMITED SULPHAMETHOXAZOLE+TRIMETHOPRIM (800 MG+1 | $1.2M | 1 | 4.4% |
| 4 | AUROBINDO PHARMA LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $1.1M | 1 | 4.2% |
| 5 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED COTRIMOXAZOLE TABLET BP 480MGCOTRIMOXAZOLE TABLET BP 480MG NOSPHARMACEUTICAL MEDICINE _ TRIMETHOPRIM B | $1.1M | 5 | 4.0% |
| 6 | APL HEALTHCARE LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $891.1K | 1 | 3.4% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $744.8K | 1 | 2.8% |
| 8 | MICRO LABS LTD TRIMETHOPRIM AND SULFAMETHOXAZOLE TABLETORIPRIM TABLETS (TRIMETHOPRIM 80MG+SULPHTRIMETHOPRIME AND SUPFAMETHOXAZOLE TABLE | $681.2K | 3 | 2.6% |
| 9 | SYNCOM FORMULATIONS (INDIA) LIMITED PHARMACEUTICAL MEDICINE _ TRIMETHOPRIM BTRIMETHOPRIM 80MG SULPHAMETHOXAZOLE400MGSULPHAMETHOXAZOLE 400 MG & TRIMETHOPRIME80 MG TABLETS | $678.2K | 7 | 2.6% |
| 10 | SOMERSET THERAPEUTICS LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $616.2K | 1 | 2.3% |
| 11 | ARBRO PHARMACEUTICALS PRIVATE LIMITED | $536.1K | 2 | 2.0% |
| 12 | JODAS EXPOIM PRIVATE LIMITED | $481.8K | 1 | 1.8% |
| 13 | MEDREICH LIMITED SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETPHARTRIM SUSPENSIONSULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS 100X10S NOS | $454.4K | 1 | 1.7% |
| 14 | PIRAMAL PHARMA LIMITED SULFAMETHOXAZOLE / TRIMETHOPRIM TABLETSSULFAMETHOXAZOLE AND TRIMETHOPRIMSULFAMETHOXAZOLE & TRIMETHOPRIM INJECTIO | $344.3K | 1 | 1.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Trimethoprim exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Micro Labs Limited | Not Listed | Yes, multiple inspec | No | Not verified | WHO inspections conducted at various facilities in India from 2012 to 2025. (ext |
| Medicamen Biotech Limited | Not Listed | Yes | No | Not verified | Listed as WHO-GMP certified. |
| Aurobindo Pharma Limited | Not Listed | Yes | No | Not verified | Listed as WHO-GMP certified. |
| Fourrts (India) Laboratories Private Limited | Not Listed | Yes | No | Not verified | Approved by LMHRA through WHO-GMP desk audit. (lmhra.gov.lr) |
| Syncom Formulations (India) Limited | Not Listed | Yes | No | Not verified | Approved by LMHRA through WHO-GMP desk audit. (lmhra.gov.lr) |
| Medreich Limited | Not Listed | Yes | No | Not verified | Listed as WHO-GMP certified. |
| Piramal Pharma Limited | Not Listed | Yes | No | Not verified | Listed as WHO-GMP certified. |
TransData Nexus reviewed the regulatory standing of 7 leading Trimethoprim exporters from India. 0 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Trimethoprim sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the nation's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Aurobindo Pharma Limited, which exported Trimethoprim worth $1.1 million (4.2%) during the analyzed period. The establishment of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone in December 2019, further solidifies the city's position as a pharmaceutical hub.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and biogenerics manufacturing. Vadodara, in particular, is home to Alembic Pharmaceuticals, a company with a significant presence in the pharmaceutical sector. The region's focus on formulations complements Hyderabad's bulk drug production, creating a comprehensive pharmaceutical supply chain.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai's strategic port facilities and well-established logistics infrastructure facilitate efficient international distribution. Companies like Formel Labs, with facilities in both Mumbai and Hyderabad, leverage this connectivity to ensure timely delivery of pharmaceuticals to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives. This zone attracts numerous pharmaceutical companies seeking cost-effective production solutions, thereby enhancing India's overall pharmaceutical manufacturing capacity.
5Sourcing Recommendations
- Diversify Supplier Base: While MICRO LABS LIMITED is a leading exporter of Trimethoprim, consider engaging with other significant suppliers like LEBEN LABORATORIES PRIVATE LIMITED and MEDICAMEN BIOTECH LIMITED to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad's bulk drug production capabilities for raw materials and Ahmedabad-Vadodara's expertise in formulations to optimize the manufacturing process.
- Optimize Logistics: Capitalize on Mumbai's export infrastructure to ensure efficient and timely distribution of Trimethoprim to international markets.
- Monitor Regulatory Compliance: Stay updated with guidelines from regulatory bodies such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to ensure compliance and maintain market access.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Trimethoprim exporters from India
Micro Labs Limited — Income Tax Department raids Micro Labs Limited
In July 2022, the Indian Income Tax Department conducted raids on multiple premises of Micro Labs Limited, including offices and promoters' residences across several states. The raids were connected to allegations of tax evasion and unaccounted distribution of freebies to medical professionals, with the tax authorities estimating the value of these freebies at approximately ₹1,000 crore and potential tax evasion over ₹300 crore. - IMPACT: Potential regulatory scrutiny may affect Micro Labs Limited's export operations, including Trimethoprim shipments.
Impact: Potential regulatory scrutiny may affect Micro Labs Limited's export operations, including Trimethoprim shipments.
Aurobindo Pharma Limited — US FDA issues observations to Aurobindo Pharma's Telangana unit
In March 2024, the US Food and Drug Administration (FDA) issued a Form 483 with seven observations to Aurobindo Pharma's subsidiary, Eugia Pharma SEZ unit in Telangana. The observations highlighted procedural and cleanliness issues, including failure to prevent contamination and inadequate training of employees involved in manufacturing processes. - IMPACT: These regulatory observations could potentially impact Aurobindo Pharma's export capabilities, including Trimethoprim products.
Impact: These regulatory observations could potentially impact Aurobindo Pharma's export capabilities, including Trimethoprim products.
Aurobindo Pharma Limited — Aurobindo Pharma's Telangana plant receives US FDA observations
In March 2024, the US Food and Drug Administration (FDA) conducted an inspection of Aurobindo Pharma's subsidiary, Eugia Pharma SEZ unit in Telangana, resulting in seven observations. The FDA noted procedural and cleanliness issues, including failure to prevent contamination and inadequate training of employees involved in manufacturing processes. - IMPACT: These regulatory observations could potentially impact Aurobindo Pharma's export capabilities, including Trimethoprim products.
Impact: These regulatory observations could potentially impact Aurobindo Pharma's export capabilities, including Trimethoprim products.
Common Questions — Trimethoprim Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which trimethoprim supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MICRO LABS LIMITED leads with 115 recorded shipments worth $7.5M. LEBEN LABORATORIES PRIVATE LIMITED (29 shipments) and MEDICAMEN BIOTECH LIMITED (49 shipments) are also established high-volume exporters.
Q How many trimethoprim manufacturers are there in India?
India has 278 active trimethoprim exporters with a combined export market of $26.4M across 2,427 shipments to 121 countries. The top 5 suppliers hold 45.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for trimethoprim from India?
Average FOB unit price: $8.75 per unit, ranging from $0.01 to $840.31. Average shipment value: $10.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 278 verified Indian exporters of Trimethoprim ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,427 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 121 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,427 Verified Shipments
278 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists